← Leaderboards
Matthew Edward Burow
Tulane University Of Louisiana
$4,380,869
Attributed
$6,397,331
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $939.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,397,331 · 4
By mechanism
R01$6,230,581 · 3
R03$166,750 · 1
Top collaborators
- David Harold Drewry8 shared
- Robert Howard Newman6 shared
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Rudy M Ortiz$3,922,550
- Linda E Hyman$11,091,909
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsPhosphotransferasesPathway InteractionsSignal TransductionSignal PathwayBiologicalLinkPlayCellsDrug DevelopmentMolecularResponseProteinsResearch PersonnelDesignGene ExpressionPhysiologicalInsightProgramsProtein KinaseCell LinePharmaceutical PreparationsCommunitiesMigration
Grant awards (20)
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$626,742
R01 · FY2025 · CA
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$595,679
R01 · FY2024 · CA
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$174,596
R01 · FY2024 · CA
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$169,251
R01 · FY2024 · CA
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$614,579
R01 · FY2023 · CA
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer (Diversity Supplement - Belgodere)$110,183
R01 · FY2023 · CA
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$636,146
R01 · FY2022 · CA
Characterization of an understudied kinase, NEK5, in acquisition of a mesenchymaland migratory cell phenotype$166,750
R03 · FY2020 · TR · contact PI
MEK5-Erk5 in breast cancer resistance$291,987
R01 · FY2014 · CA · contact PI
MEK5-Erk5 in breast cancer resistance$282,926
R01 · FY2013 · CA · contact PI
MEK5-Erk5 in breast cancer resistance$300,953
R01 · FY2012 · CA · contact PI
MEK5-Erk5 in breast cancer resistance$300,923
R01 · FY2011 · CA · contact PI
MEK5-Erk5 in breast cancer resistance$322,449
R01 · FY2010 · CA · contact PI
P13K/AKT crosstalk with ER-signaling and cell survival$275,977
R01 · FY2008 · DK · contact PI
P13K/AKT crosstalk with ER-signaling and cell survival$281,609
R01 · FY2007 · DK · contact PI
P13K/AKT crosstalk with ER-signaling and cell survival$65,560
R01 · FY2007 · DK · contact PI
P13K/AKT crosstalk with ER-signaling and cell survival$290,021
R01 · FY2006 · DK · contact PI
P13K/AKT crosstalk with ER-signaling and cell survival$297,000
R01 · FY2005 · DK
P13K/AKT crosstalk with ER-signaling and cell survival$297,000
R01 · FY2004 · DK
P13K/AKT crosstalk with ER-signaling and cell survival$297,000
R01 · FY2003 · DK